|
C17ORF80 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.618300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.081000E-03 |
| Normal-vs-Stage2 |
1.713420E-01 |
| Normal-vs-Stage3 |
3.779400E-01 |
| Normal-vs-Stage4 |
4.623200E-01 |
| Stage1-vs-Stage2 |
8.806000E-01 |
| Stage1-vs-Stage3 |
5.795000E-01 |
| Stage1-vs-Stage4 |
9.381000E-01 |
| Stage2-vs-Stage3 |
6.208800E-01 |
| Stage2-vs-Stage4 |
8.829600E-01 |
| Stage3-vs-Stage4 |
8.169200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.449800E-04 |
| Normal-vs-AfricanAmerican |
8.105700E-02 |
| Normal-vs-Asian |
5.915600E-01 |
| Caucasian-vs-AfricanAmerican |
3.482600E-01 |
| Caucasian-vs-Asian |
7.803800E-01 |
| AfricanAmerican-vs-Asian |
9.970000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.822900E-03 |
| Normal-vs-Female |
5.683800E-03 |
| Male-vs-Female |
3.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.029200E-01 |
| Normal-vs-Extreme_Weight |
6.012200E-02 |
| Normal-vs-Obese |
4.294100E-02 |
| Normal-vs-Extreme_Obese |
1.807640E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.964800E-01 |
| Normal_Weight-vs-Obese |
5.928400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.853200E-01 |
| Extreme_Weight-vs-Obese |
8.683400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.106600E-01 |
| Obese-vs-Extreme_Obese |
6.449400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.365900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.27479999999058E-05 |
| Normal-vs-Age(61-80Yrs) |
8.306000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.492800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.900600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.722030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.500300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.216040E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.268250E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.311580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.63099999997518E-06 |
| Normal-VS-Type2 PRCC |
4.004200E-01 |
| Normal-VS-KIRP CIMP |
6.861600E-03 |
| Normal-VS-Unclassified PRCC |
6.773900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.014060E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.203140E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.062200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.069780E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.723210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.896400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.745000E-01 |
| Normal-vs-N1 |
1.818020E-01 |
| Normal-vs-N2 |
6.427000E-01 |
| N0-vs-N1 |
3.064000E-01 |
| N0-vs-N2 |
4.838200E-01 |
| N1-vs-N2 |
3.848800E-01 |
|
|
